In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by Travis Engelhaupt, digital experience director, and Naomi Lovell, project manager. Together, they discuss website trends and best practices.

Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

This week’s research roundup features a multicenter retrospective study on clinicopathologic predictors of renal outcomes in light chain cast nephropathy.

Matthew Binnicker, Ph.D., Director of Clinical Virology at Mayo Clinic, was recently featured in an interview with Fox News on the COVID-19 infection.

Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.

This week’s research roundup features a study on utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.

In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Matthew Binnicker, Ph.D., discusses the need for laboratory testing for the diagnosis and management of fast-spreading viral infections.

View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of February 2020.

This week’s research roundup features a study on the contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort.

Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken due to the results of this testing.

Mayo Clinic Laboratories provides evaluation and consultation for the diagnosis and treatment of patients with hereditary and acquired hematologic disorders.

This week’s research roundup features a study on hippocampal avoidance during whole-brain radiotherapy, plus memantine for patients with brain metastases.

Jane Hermansen, MT(ASCP), was recently featured in 360Dx discussing new federal regulations aimed at hospital price transparency.